The Role of Overweight and Obesity in the Cardiorenal Syndrome.
about
Basic science: Pathophysiology: the cardiorenal metabolic syndromeEvidence-based hypertension treatment in patients with diabetesOver-nutrition and metabolic cardiomyopathyInsulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulatorsThe effects of environmental chemicals on renal functionMitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndromeFeeling the pressure: (patho) physiological mechanisms of weight gain and weight loss in humans.Childhood-Adolescent Obesity in the Cardiorenal Syndrome: Lessons from Animal Models.Cardiorenal metabolic syndrome and cardiometabolic risks in minority populationsTT genotype of rs2941484 in the human HNF4G gene is associated with hyperuricemia in Chinese Han men.Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.Metformin in peritoneal dialysis: a pilot experienceFructose and uric acid: is there a role in endothelial function?Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemEffect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort.DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese ratDiabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyThe pathophysiology of hypertension in patients with obesity.Obesity and heart failure as a mediator of the cerebrorenal interaction.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Physical Activity in the Prevention of Chronic Kidney DiseaseCardiac insulin resistance and microRNA modulators.Prenatal Programming and Epigenetics in the Genesis of the Cardiorenal SyndromePhosphate Metabolism in Cardiorenal Metabolic Disease.Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.Use of Metformin in Patients with Kidney and Cardiovascular Diseases.Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney diseasePigmented rice bran and plant sterol combination reduces serum lipids in overweight and obese adults.Overweight female rats selectively breed for low aerobic capacity exhibit increased myocardial fibrosis and diastolic dysfunction.Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors.Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese ratsDPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.Dietary phthalates and low-grade albuminuria in US children and adolescents.Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.Cardiorenal metabolic syndrome and diabetic cognopathy.
P2860
Q26823487-9D4075AA-F8D9-4088-99FE-87B02B27333CQ26851738-23DA4182-3A0A-4E0A-8970-32B83A2F00D6Q27000683-27309802-DB9E-41D6-9DED-E2B2A39C4D3AQ28081458-B26E7FBC-2C6D-4BB8-BA0C-697EB80D621CQ28397401-4F308520-1B64-4D7A-ACD7-697FC35A9B17Q28650861-E0D08821-55FB-410E-86AB-50812481A926Q30244320-63D7D817-CED5-4A17-81C3-A61D8615B258Q30412404-CE1B4ACA-A443-45DE-B971-893DA55C5E46Q33625733-CF2196A0-86EF-4D34-B6CC-AA3441D025CAQ33688869-8318BA13-9529-49A0-9AA0-E8061E35B03BQ33829331-4F6158E5-1B11-4BA4-AAB8-F9232A194FF0Q33837650-2DA6B19E-07BD-437E-8220-7EB81F3C78EDQ33854358-34C42B67-C603-4C52-A6D8-1FA0B3AA53F8Q34027687-8EC805E6-C081-482A-B4FE-34D292C358A1Q34062829-3AD9B167-A79A-443B-B67D-4BEBD2127141Q34181148-DE067784-4EE8-4895-95B0-CD8CB8FC3F6EQ34270500-4AE3D20D-1E33-4464-AA9C-C930E461C3EEQ34609759-8BAD4679-9445-4A76-9B0C-8E4D6B68017BQ35005356-8999A64B-8445-47E4-9751-E0C2B0BFA125Q35021492-936AD5A9-36E4-41E9-8DBA-BAC4CA0A6D0CQ35044027-C43C7EFE-DE0E-40FE-8F5D-18848184CD9EQ35054122-CDDB0E9E-914E-4989-96A9-25BDD2F20A80Q35149800-00D49901-C9FA-4741-BFCB-F5881B1A00E6Q35251097-2CB82C45-063D-41C5-908F-3D8FC5712A68Q35546314-267ECEBD-FE8D-4DE1-9471-0B499C1E8C72Q35546322-3E9DE439-7972-4FF7-BF4E-9876C4C73471Q35630861-47D03834-86B5-44BC-B3D5-92BA493FAA4FQ35688570-43A89054-22BC-4668-83FC-D5E24128388DQ35695693-BBEEC604-1B28-418A-909E-A862437AB3B7Q35736827-9D5F2839-FF3C-46ED-A492-1B597258764DQ35900941-38E9F8CD-7CE1-4F6C-B516-0D39A53A7A21Q36551394-FE680A24-9650-46E9-A92E-E011B688C069Q36551406-12DC81C5-88D1-4FA0-95B5-BAC043478AE9Q36674142-DF126722-89E3-406A-95BF-448F224D7D27Q36946065-A6CAAA5E-2DCD-402B-AFDB-290062EE2352Q37095161-C718B2F9-F9ED-4723-A487-15EF603E0C18Q37258157-EB1D78C3-645B-49EA-832D-8BBD4FFDE486Q37426963-5638BD1A-1831-48C8-A9A3-5868B0E8BBAFQ37447055-353F116B-0AD4-471D-A235-D9C3049059BDQ37514020-33E4734D-A6D6-4969-A62F-827CDE73A477
P2860
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@ast
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@en
type
label
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@ast
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@en
prefLabel
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@ast
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@en
P2860
P356
P1433
P1476
The Role of Overweight and Obesity in the Cardiorenal Syndrome.
@en
P2093
James R Sowers
Melvin R Hayden
P2860
P356
10.1159/000322822
P577
2011-01-17T00:00:00Z